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Abstract:-  40 
This study describes the characterization of four KPC-2-producing Klebsiella pneumoniae strains 41 
from neonates belonging to a single sequence type 147 (ST147) in relation to carbapenem resistance 42 
and explores probable mechanisms of differential colistin resistance among the clonal cluster. 43 
 Whole Genome Sequencing revealed that the isolates were nearly 100% identical harbouring 44 
resistance genes (blaKPC-2,OXA-9,CTX-M-15,SHV-11,OXA-1,TEM-1B, oqxA, oqxB, qnrB1, fosA, arr-2, sul1, 45 
aacA4, aac(6’)Ib-cr, aac(6’)Ib), and several virulence genes. blaKPC-2 was the only carbapenem-46 
resistant gene found, bracketed between ISKpn7 and ISKpn6 of Tn4401b on a non-conjugative 47 
IncFII plasmid. Remarkably, one of the clonal isolates was resistant to colistin, the mechanistic basis 48 
of which was not apparent from comparative genomics. The transmissible colistin resistance gene, 49 
mcr, was absent. Efflux pump inhibitor CCCP rendered 32-fold decrease in the minimum inhibitory 50 
concentration of colistin in the resistant isolate only. acrB, tolC, ramA, and soxS genes of the 51 
AcrAB-TolC pump system overexpressed exclusively in the colistin-resistant isolate, although the 52 
corresponding homologs of AcrAB-TolC pump, regulators and promoters were mutually identical. 53 
No change was observed in the expression of other efflux genes (KpnEF & KpnGH) or Two 54 
Component System genes (phoP/phoQ, pmrA/pmrB). 55 
 We postulate that colistin resistance in one of the clonal KPC-2-producing isolate was due to 56 
overexpression of AcrAB-TolC pump. This study is probably the first to report clinical clonal K. 57 
pneumoniae isolates with differences in colistin susceptibility. The presence of carbapenem-resistant 58 
isolates with differential behavior in the expression of genomically identical pump system indicates 59 
the nuances of the resistance mechanisms and the difficulty of treatment thereof.  60 
Keywords: KPC-2, Klebsiella pneumoniae, ST147, Colistin resistance, AcrAB-TolC pump, Two 61 
Component System. 62 
1. Introduction: - 63 
Carbapenem resistance has challenged the medical system all around the globe. The repertoire of 64 
carbapenem-resistant genes (class A, B and D enzymes) and their spread via mobile genetic 65 
elements have compounded the problem. Klebsiella pneumoniae carbapenemases (KPCs), class A 66 
enzymes, confer decreased susceptibility to virtually all β-lactams and are mostly present in 67 
Klebsiella pneumoniae [1,2]. K. pneumoniae causes a wide range of infections, such as pneumonia, 68 
urinary tract infections, septicemia, liver abscesses etc., not only in immunocompromised as well as 69 
in immunosufficient ones [3]. According to the resistance map of CDDEP reports (2017) for India, 70 
59% of K. pneumoniae are resistant to carbapenems, and this has increased from 56% in 2015 71 
(https://resistancemap.cddep.org/).  72 
 Till now 46 types of KPCs have been reported worldwide 73 
(https://www.ncbi.nlm.nih.gov/pathogens/isolates#/refgene/KPC). Though, the spread of KPC had 74 
been initiated by a single dominant clone sequence type 258 (ST258), it has now been reported 75 
among varied STs across the world [1,2]. 76 
 With increased resistance towards carbapenems, colistin is being used as one of the last 77 
treatment options [1]. Isolates which are resistant to both colistin and carbapenem have been 78 
reported [4]. Such isolates are dreaded in clinical setups, particularly in neonatal intensive care units 79 
(NICU) as treatment options are already limited in the newborns. Colistin being a cationic peptide, 80 
acts by disrupting the negatively charged lipopolysaccharide (LPS). Resistance to colistin is 81 
generally attributed to upregulation of two-component system genes (TCSs) such as p oP/phoQ and 82 
pmrA/pmrB. Constitutive activation of these genes leads to modification of LPS, leaving colistin 83 
ineffective. Another important mechanism of resistance is by mutations/inactivation of mgrB, a 84 
transmembrane protein, acting as a negative feedback loop for phoP/phoQ system. Nevertheless, 85 
many other mechanisms work simultaneously resulting in colistin resistance. With the emergence of 86 
mobilized colistin resistance gene, mcr, spread of resistance has increased several folds [4–6].87 
 This study characterizes four clonal K. pneumoniae collected from a NICU in terms of 88 
carbapenem resistance. The clonal isolates also showed differences in resistance to colistin. Given 89 
the fact that such difference in colistin resistance in genetically identical carbapenem-resistant 90 
isolates is rarely observed, and analysis of the mechanism of colistin resistance among these isolates 91 
was also carried out.  92 
2. Materials and Methods: - 93 
2.1. Identification of bacterial isolates, antimicrobial susceptibility testing and phenotypic assay 94 
for Extended Spectrum Beta-Lactamases (ESBLs) and Carbapenemases: 95 
Bacterial isolates were collected from the blood of septicemic neonates from the neonatal intensive 96 
care unit of a tertiary care hospital of Kolkata, West Bengal by standard procedure. Isolation was 97 
done from the year 2013-2016, in which a total of 195 Enterobacteriaceae were recovered. Isolates 98 
were identified by in-house biochemical tests and further confirmed by VITEK® 2 Compact system 99 
(bioMérieux, Marcy-l'Étoile, France). Minimum inhibitory concentrations (MICs) were determined 100 
by E-test method (bioMérieux, Marcy-l'Étoile, France) for different antimicrobial agents.  For 101 
colistin and fosfomycin (MP Biomedicals, California, USA), broth micro dilution and agar dilution 102 
were carried out respectively [7]. Results were analyzed according to Clinical & Laboratory 103 
Standards Institute (CLSI) for all antibiotics except for colistin & tigecycline which were interpret d 104 
according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. 105 
Since the breakpoint of tigecycline was not available for K. pneumoniae in EUCAST, thus the 106 
breakpoint for Escherichia coli in EUCAST was used for K. pneumoniae (susceptible ≤ 0.5 mg/L; 107 
resistant > 0.5 mg/L) [8,9]. 108 
 Isolates were tested for the production of ESBLs and carbapenemases with the ROSCO 109 
tablets according to manufacturer’s instruction. Isolates exhibiting an increase of ≥5 mm in the 110 
inhibition zone of the combination disc with respective antibiotics were categorized as positive. 111 
[Rosco Diagnostica A/S, Taastrup, Denmark]. 112 
2.2. Genotypic determinants in K. pneumoniae isolates: 113 
Based on the susceptibility pattern and phenotypic results, polymerase chain reaction (PCR) was 114 
done for the following β-lactamase genes (blaCTX-M,TEM,SHV,OXA-1), AmpC genes (blaMOX,CMY,DHA,ACC, 115 
MIR/ACT,FOX), carbapenemase genes (blaVIM,IMP,SPM-1,GIM-1,SIM-1,NDM-1, blaOXA-48, blaKPC,SME,IMI,GES,NMC), 116 
16S rRNA methylase encoding genes (rmtA, rmtB, rmtC, rmtD & armA), flouroquinolone genes 117 
(qnr-A,B,S, qepA, aac(6′)-Ib, aac(6′)-Ib-cr),  addiction systems and virulence genes as described 118 
previously [10]. Plasmid types of the isolates were identified by PCR based replicon typing (PBRT) 119 
[11]. 120 
Primer walking was done to discern the genetic environment of the carbapenemase genes [2]. 121 
Primer sequences have been enlisted in Table S1. 122 
2.3. Whole genome sequencing (WGS): 123 
Total genomic DNA was extracted using the QIAamp DNA kit, and quantified using the Qubit 3.0 124 
(Thermo Fisher Scientific). DNA libraries were prepared for paired end sequencing (2x301 cycles) 125 
using Nextera XT (Illumina Inc., San Diego, CA). Whole genome sequencing (WGS) was 126 
performed using the v3 chemistry on the Illumina MiSeq platform (Illumina Inc., San Diego, CA). 127 
Quality control of raw reads included fastqc (0.11.2), and quality and adaptor trimming was 128 
performed using Trimgalore (0.4.3). Reads were assembled in contigs using the de novo assembler 129 
SPAdes (3.9.0) (.fasta) and were aligned to the original fastq reads using BWA aligner (0.7.15). Any 130 
assembly mapping errors in the contigs was corrected using Pilon (1.22). Assembly metrics were 131 
evaluated using Quast (2.1). Genomes (contigs) were annotated using Prokka (1.12) and the resulting 132 
.gbk file was viewed in Artemis (genome viewer, Sanger, UK). Resulting .gff files of Prokka were 133 
used to create a core genome alignment using Roary (v3.12.0). Fasttree was used to build the 134 
phylogenetic tree (.nwk file) and visualized in Interactive Tree Of Life (iTOL). BLAST Ring Image 135 
Generator (BRIG) [12] was used to evaluate genome wide sequence similarity using a KPC-2-136 
producing ST11 Klebsiella pneumoniae subsp. pneumoniae HS11286 as a reference genome. Single 137 
nucleotide polymorphism (SNP) analysis was done using kSNP3.0 using the file generated with 138 
Prokka [13].  139 
 ResFinder (3.0), PlasmidFinder (1.3) were used for genotypic characterization. Virulence 140 
genes were assessed by Institut Pasteur MLST and whole genome MLST databases 141 
(http://bigsdb.pasteur.fr/klebsiella/klebsiella.html) as well as by Kleborate pipeline 142 
(https://github.com/katholt/Kleborate) for more detailed analysis of the isolates. Promoter sequence 143 
analysis was done (http://www.fruitfly.org/seq_tools/promoter.html). Individual genes were BLAST 144 
searched against the four genomes along with MUMmer alignment. Genomes were visualized using 145 
SNAP Gene tool (4.3.8). INTEGRALL database (http://integrall.bio.ua.pt) was used to search the 146 
integron sequences. TETyper (https://omictools.com/tetyper-tool) was used with the suggested 147 
parameters, to type the transposable genetic element from paired-end sequencing data. 148 
2.4. Multi-locus Sequence Typing (MLST) and Pulse Field Gel Electrophoresis (PFGE): 149 
To identify the sequence types (ST), MLST database (https://cge.cbs.dtu.dk/services/MLST/) was 150 
used. 151 
 PFGE was performed using PulseNet standardized procedures with XbaI (50 U/plug) 152 
(http://www.cdc.gov/pulsenet/protocols.html) in a CHEF-DR III system (Bio-Rad Laboratories, 153 
Hercules, CA, USA). XbaI macrorestriction patterns were visually interpreted according to Tenover 154 
criteria [14]. 155 
2.5. Transmissibility of carbapenemase carrying plasmid: 156 
The transfer of carbapenemase gene into E. coli J53Azr strain was performed by both solid- and 157 
liquid-mating conjugation techniques at varying temperatures. Electroporation was carried out with 158 
purified plasmid DNA [15] into E. coli DH10B (Invitrogen, California, USA) using a Gene Pulser II 159 
(Bio-Rad Laboratories, Hercules, CA, USA). Transformants were selected on LB agar plates (BD 160 
BBL, MD, USA) supplemented with ertapenem (0.25mg/L) (Sigma-Aldrich, St Louis, MO, USA). 161 
Transformants retrieved were subjected to genotypic confirmation of carbapenemase and other β-162 
lactamase genes followed by susceptibility testing. 163 
2.6. Evaluating mechanisms of colistin resistance - 164 
WGS data was evaluated using ResFinder for the presence of mcr r its variant genes. 165 
2.6.1. Efflux pump activity: 166 
MIC of colistin was determined in the presence of efflux pump inhibitors (EPIs) such as carbonyl 167 
cyanide 3-chlorophenylhydrazone (CCCP; 10mg/L) and 1-(1-naphthylmethyl)-piperazine (NMP; 168 
25mg/L) (Sigma-Aldrich, St Louis, MO, USA) to assess the role of efflux pump genes [16, 17]. MIC 169 
was done in triplicate in separate experiments. 170 
2.6.2. Gene expression using real-time PCR (RT–PCR): 171 
The mRNA expression level of TCS genes viz phoP/phoQ, pmrA/pmrB were analyzed [4,5]. Based 172 
on the phenotypic expression of EPIs, expression of transmembrane protein of AcrAB-TolC (acrB), 173 
acrA, tolC and their regulators (soxS and ramA) were studied [18]. Additionally, expression of 174 
KpnEF (small multidrug resistance family, SMR) and KpnGH (Major facilitator superfamily, MFS) 175 
efflux pumps [19, 20] were also analyzed.  176 
 Isolates were inoculated overnight in cation-adjusted Mueller-Hinton broth (BD BBL, MD, 177 
USA) in the presence of colistin sulphate (0.125mg/L) at 37°C with shaking. Overnight cultures 178 
were diluted (1/100) in cation-adjusted Mueller–Hinton broth containing colistin sulphate 179 
(0.125mg/L) and grown to mid-logarithmic phase at 37°C with vigorous shaking (230 rpm). RNA 180 
was harvested using NucleoSpin® RNA purification kit (Machery-Nagel, Germany) according to the 181 
manufacturer’s instructions. RNA yield and quality were determined using a NanoDrop 182 
biophotometer plus (Eppendorf, Hamburg, Germany) followed by RNase-free DNase treatment 183 
(New England Biolabs, USA) and purity was assessed by PCR.  184 
 Two micrograms of the isolated total RNA were reverse transcribed to cDNA using the 185 
RevertAid RT Reverse Transcription Kit (Thermo Fisher Scientific, Massachusetts, USA). 186 
Expression of the target genes were quantified using Power SYBR Green PCR Master Mix (Applied 187 
Biosystems, California, USA) in StepOne Plus Real-Time PCR system (Applied Biosystems, 188 
California, USA). The reactions were performed with 0.5 mM primer in 20 µL reaction volumes in 189 
duplicate in separate experiments. The relative RNA expression levels were calculated according to 190 
the ΔΔCt method, normalized with the ribosomal housekeeping genes (rp L for TCS, KpnEF, 191 
KpnGH pumps, and rrsE for AcrAB pump). Relative expression of each target gene was then 192 
calibrated against the expression of a K. pneumoniae (EN5219) isolate susceptible to all antibiotics 193 
tested, which served as the reference strain (expression=1). A ≥2-fold increase in the expression of 194 
genes when compared with the reference strain was considered as cut-off to denote significant 195 
overexpression [21]. 196 
2.6.3. Outer membrane protein profile: 197 
Whole-cell extracts of the isolates were separated on 12% SDS–polyacrylamide gels and transferred 198 
to Immobilon-P membrane (Merck Millipore, Massachusetts, USA) following standard protocols. 199 
An isolate of E. coli (S205) which retained both the outer membrane proteins (OMPs) (OmpC/F) 200 
was used as a control for the western blots. Porins were detected using polyclonal anti-OmpC/F 201 
antibody with 1:3000 dilutions as described earlier [22].  202 
3. Results and Discussion: 203 
3.1. Identification of isolates and clinical presentation of neonates: 204 
Of the different Enterobacteriaceae evaluated during the period of 2013-2016, only four isolates 205 
possessed blaKPC and all four were K. pneumoniae. These four isolates were recovered during 206 
September, 2015 to December, 2015 indicating the emergence of this gene in this unit. There were 207 
no further cases of blaKPC-harbouring isolates till end of 2016. The four isolates were named as Kp1 208 
(EN5226), Kp2 (EN5261), Kp3 (EN5269), and Kp4 (EN5271) and analyzed in detail. Henceforth, 209 
isolates will be referred to as Kp1, Kp2, Kp3 and Kp4 isolated from neonates P1, P2, P3, and P4 210 
respectively.  211 
 The details of the clinical status of the neonates are presented in Table S2. P1 had an 212 
extended stay of nearly a year and P2 was admitted for 2 months. P3 and P4 were in the unit for 213 
almost a month (Table S2). Since blaKPC was never recovered from this unit before or after the 214 
aforesaid period, hence P1 carrying the blaKPC was suspected to be the index case and all neonates 215 
had overlapping stay, indicating possibility of cross transmission. None of the neonates were treated 216 
with colistin during their stay. Other studies have also reported nosocomial outbreaks [23] with 217 
KPC-producing strains including outbreaks in neonatal units [24].218 
3.2. Antibiotic susceptibility testing and phenotypic detection of ESBLs and carbapenemases: 219 
Antibiotic susceptibility tests for the four isolates showed similar pattern of susceptibility for 14 220 
antimicrobials except for colistin. Kp1, Kp3, and Kp4 were susceptible to colistin whereas Kp2 was 221 
resistant (MIC: 8mg/L). Kp1-Kp4 was susceptible to gentamicin, cefoxitin, meropenem, and 222 
tigecyline only (Table 1).  223 
 ROSCO combination tablets indicated presence of ESBLs and KPC which were further 224 
verified by PCR/WGS. 225 
3.3. Resistance and virulence determinants of K. pneumoniae: 226 
Resistome analysis (≥98% identity and coverage) showed that the four strains possessed blaKPC-2 as 227 
the only carbapenemase gene apart from the following genes: 5 β-lactamase genes blaOXA-9, blaCTX-228 
M-15, blaSHV-11, blaOXA-1, and blaTEM-1B; aacA4, aac(6')Ib and aadA1 (aminoglycoside resistance-229 
encoding genes); aac(6')Ib-cr, qnrB1, oqxA, and oqxB (quinolone resistance); fosA for fosfomycin; 230 
catB3 for phenicol; arr-2 for rifampicin and sul1 for sulphonamide (Table 2). Resistance 231 
determinants mentioned above were also detected by conventional PCRs to validate the results 232 
obtained from WGS analysis. vagCD was the only addiction system found in these isolates (Table 233 
1). In accordance to earlier reports, our study also revealed association of KPC with resistance 234 
determinants conferring resistance to other antibiotics [1]. KPC (serine β-lactamases) are efficient in 235 
hydrolyzing cephalosporins, monobactams, and carbapenems (imipenem, and ertapenem). KPCs 236 
often evade detection by routine susceptibility screening as they are not as efficient as other 237 
carbapenemases, hence, leading to treatment failures and possess an exceptional potential for 238 
dissemination [1]. 239 
 Different virulence genes, such as fimH (type-1 fimbrial adhesion protein), wabG & uge 240 
(biosynthesis of the outer core lipopolysaccharide; capsule and smooth lipopolysaccharide 241 
respectively), kfuBC (iron-uptake system), ybt (siderophore yersiniabactin cluster), mrk (type-3 242 
fimbrial gene cluster), and fyuA (yersiniabactin receptor) were found within the genomes of the four 243 
isolates. Presence of these genes were also reported in K. pneumoniae from clinical setups [25, 26]. 244 
Isolates in this study harbored KL10 (K-loci), O3/O3a (O-loci) bearing wiz420 and wcz11 capsular 245 
genes.  All the four strains belonged to yersiniabactin sequence type 135 (ybST135) and carried 246 
ybt14; ICEKp5 as the integrative conjugative element (Table 2). These virulence determinants 247 
provide the isolates with both adaptive advantages and offensive capabilities to persist and cause 248 
disease, thereby making K. pneumoniae an efficient nosocomial pathogen and good colonizer. 249 
3.4. Transmissibility of KPC-bearing plasmids: 250 
Transfer of KPC-2-bearing plasmid was unsuccessful by conjugation. Transformants (TF) were 251 
obtained on Luria agar plate supplemented with 0.25mg/L ertapenem upon electroporation. Presence 252 
of blaKPC-2, qnrB1, oqxA, oqxB, aac (6′)-Ib-cr were found in Kp2-Kp4 whereas only blaKPC-2 was 253 
found in transformants of Kp1 (Table 1). MICs of transformants are presented in Table 1. 254 
Plasmid-scaffold genes such as IncFIB, IncFII, and IncR were found by PBRT (Table 1) and 255 
an additional Col plasmid was found by PlasmidFinder tool (Table 2). Plasmid analysis revealed 256 
presence of blaKPC-2 on IncFII plasmid. blaKPC-2 has been reported to reside on numerous plasmid 257 
types, such as IncF, IncI2, IncX, IncA/C, IncR, and ColE1. IncFIIK replicon is the preferred one [2]. 258 
IncF/ IncFII plasmids are generally conjugative [27] but in this study the IncFII plasmids were non-259 
conjugative and could be transferred only by electroporation. This could also be a reason for its 260 
restrictive spread in the unit. Only four neonates were infected and spread of bl KPC-2 to other species 261 
was not observed (unpublished data). 262 
Genetic environment of blaKPC-2 was determined by primer walking method which was 263 
further validated by WGS data. blaKPC-2 was found to be within a Tn3-based transposon, Tn4401 and 264 
TETyper revealed it to be Tn4401b. It harbored two different types of IS elements. ISKpn7 265 
belonging to IS21 family, in the upstream of blaKPC-2, and ISKpn6, a member IS1182 family, on 266 
downstream of the gene. Presence of transposase, tnpA and resolvase, tnpR of Tn4401b were found 267 
at the upstream of blaKPC-2 right before ISKpn7 (Fig. 1). The results corroborate with other studies 268 
reporting the association of blaKPC-2 with Tn4401b [2]. Presence of two IS elements each having its 269 
own transposase activity along with transposase of the Tn3-based transposon, itself initiate a strong 270 
transposition event. This facilitates movement of blaKPC-2 among various plasmids as well as 271 
different organism leading to worldwide dissemination of the gene.  272 
In875 class 1 integron was found in Kp1-Kp3. In Kp4, the 3′CS region could not be retrieved, 273 
though it carried class 1 integron. In all of the isolates, insertion of S.ma.I2 group IIc intron has been 274 
found within the attC site of the arr2 gene cassette (Fig. 2). 275 
3.5. Molecular typing of K. pneumoniae: 276 
BRIG analysis revealed that the four genomes had significant levels of similarities with the reference 277 
strain (Fig. 3). Nearly 100% identity across the genomes was evident, though the four genomes also 278 
have minute differences among themselves which is common between clonal populations. The core 279 
genome alignment and resulting phylogenetic tree shows that the four isolates group in 2 clusters. 280 
Kp2 and Kp4 are more closely related, as are isolates Kp1 and Kp3 (Fig. 4A).  MLST revealed that 281 
all the four isolates belonged to a single sequence type 147 (ST147) (Table 2). This finding matched 282 
with indistinguishable band patterns in PFGE (Fig. 4B). 283 
Presence of blaKPC has been reported in almost 115 different STs worldwide of which, ST258 284 
is the leading one [2,23]. KPC-2 was found in ST258 in Europe and USA, and in ST37, ST392, 285 
ST395, and ST11 in Asia-Pacific regions [2]. In our study, blaKPC-2 was harbored in ST147 K. 286 
pneumoniae. Interestingly, the ST147 K. pneumoniae clone has been associated with different 287 
carbapenemases including NDM, KPC, OXA-48, OXA-181 or OXA-204 enzymes; making this ST a 288 
globally high-risk clone [28-30]. Presence of ST147 K. pneumoniae has been reported from India 289 
previously in association with colistin resistance [31] but presence of blaKPC-2 was never encountered 290 
in ST147 from India.  291 
3.6. Analysis of colistin resistance: 292 
Of the four clonal isolates, one (Kp2) demonstrated raised MIC value (8mg/L) for colistin. Clonal 293 
isolate with difference in susceptibility is rarely encountered. Though an earlier study had reported 294 
variations in susceptibility to meropenem in clonal K. pneumoniae [32] but to the best of our 295 
knowledge, no such variation in terms of colistin has been reported yet. 296 
 WGS data was extensively explored in search of recently reported mcr genes and its variants. 297 
No such gene was found to be present within the genome of the colistin-resistant strain. SNP 298 
analysis showed a total of 12 SNPs within the core genome of Kp2 which differ with the other 3 299 
strains (Kp1, Kp3, Kp4). But none of these genes have been reported to be associated with colistin 300 
resistance. Details of the SNPs have been included in Table S3.  301 
 Colistin resistance is chiefly mediated by covalent modification of the lipid A moiety of 302 
lipopolysaccharide (LPS) by 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine 303 
(PEtN), resulting in reduced binding ability of colistin to the LPS [33]. Based on the established 304 
mechanisms of colistin resistance, expression of TCSs was studied by realtime RT-PCR. phoP, 305 
phoQ, pmrA, and pmrB did not show significant change among the isolates when compared with 306 
reference sample EN5219 (Table 3). Sequences of these genes along with other genes known to play 307 
a significant role in colistin resistance such as mgrB, pmrC, pmrD (responsible for downstream 308 
modification of LPS), crrAB (two-component regulator of pmrAB), and arnBCADTEF-pmrE 309 
(operon that mediate synthesis and transfer of L-Ara4N to LPS) were analyzed from the WGS data 310 
but no change was observed in their sequences, which ruled out the involvement of the TCSs and 311 
other modifying genes for colistin resistance in Kp2.   312 
A decrease in MIC of colistin from 8mg/L to 0.25mg/L (32-fold) was found in case of Kp2 in 313 
the presence of CCCP (Table 3). No such change was encountered for other isolates either with 314 
CCCP or with any other EPI. CCCP is a nonspecific EPI and acts on the energy source of several 315 
efflux pumps as well as on other membrane proteins. Decreased MIC of colistin in the presence of 316 
CCCP might indicate a probable role of efflux pump in colistin resistance in Kp2 [17, 34].  317 
RT-PCR showed overexpression of regulators and efflux pump genes viz. ramA (5.5-fold), 318 
soxS (2.7-fold), acrB (4.5-fold), and tolC (2-fold), in Kp2 only when compared with the colistin-319 
susceptible K. pneumoniae (EN5219) (Table 3) and Kp1, Kp3, and Kp4. This further substantiated 320 
the change in MIC value for colistin in presence of CCCP in Kp2.  This indicated role of an active 321 
AcrAB-TolC efflux pump conferring colistin resistance in Kp2. Padilla et al. (2010) also reported 322 
the presence of an energy-dependent efflux of colistin by efflux pump gene, acrB [17] similar to our 323 
observation.  324 
Overexpression of soxRS has been found to induce colistin hetero-resistance in E t robacter 325 
sp. [35] which triggered upregulation of acrA and tolC. Though upregulation of soxS has been found 326 
in the study, yet no change in the sequences of soxS and its regulator, soxR have been noticed among 327 
the strains. As there was overexpression of acrB, tolC and its regulators ramA, their sequences were 328 
analyzed but no differences were noticed in the WGS data of the four isolates. Since, ramA is the 329 
global regulator of acrB, the promoter sequences of ramA, soxS, acrB, and tolC were also assessed 330 
with no differences to be identified from the genomic data. Further, sequences of local repressor of 331 
ramA, acrA, and acrB, (ramR, and acrR, respectively) were investigated, but no variation was 332 
noticed in these gene sequences. Similar observations for the overexpressed AcrAB-TolC pump and 333 
ramA have been made in other studies, with no genetic background to substantiate such findings, 334 
thereby indicating presence of an alternate mechanism regulating expression of these genes [17,36]. 335 
ramA mediated alteration of lipid A moiety in K. pneumoniae has also been reported to result in 336 
altered susceptibility to colistin [37]. Hence, increased ramA levels can also mediate LPS alterations, 337 
which along with the AcrAB-TolC likely contributed towards increased survival in presence of 338 
colistin. In this study also, Kp2 had increased expression of ramA. Therefore, it is likely that a 339 
functional AcrAB-TolC pump and ramA are crucial in mediating decreased susceptibility towards 340 
colistin in Kp2.  341 
KpnEF can efficiently efflux colistin whereas KpnGH acts as an intrinsic resistance 342 
determinant in K. pneumoniae [19, 20]. However, in our study, the four isolates showed similar level 343 
of expression for both the SMR and MFS type efflux pumps implying no role of these efflux pumps 344 
towards colistin resistance. 345 
Apart from these, presence of a new transmembrane protein, Enterobacter colistin resistance 346 
gene (ecr) corresponding to colistin resistance has been reported [38]. But no such homologue was 347 
found to be present in the genome of Kp2. 348 
Additionally, resistance to colistin is also attributed to change in porin profile among 349 
Enterobacteriaceae [39]. All the isolates showed similar pattern of porins, loss of OmpK35 but intact 350 
OmpK36. With no observed difference in the profile of porins in the colistin-resistant and 351 
susceptible isolates, it was concluded that OMPs had no role to play towards colistin resistance in 352 
this study. 353 
4. Conclusion- 354 
This study reports the emergence of KPC-2 in ST147 K. pneumoniae isolated from septicemic 355 
neonates. The strains showed 100% mutual identities and possessed a repertoire of resistance and 356 
virulence determinants. A difference in colistin susceptibility among the indistinguishable strains 357 
was attributed to AcrAB-TolC pump overexpression. The present study is probably the first to report 358 
such differences in colistin susceptibility for clonal K. pneumoniae isolates and similar occurrence 359 
has never been demonstrated in clinical isolates. WGS data did not indicate any change in the 360 
homologs known to be involved in the expression of the AcrAB-TolC pump system. This 361 
differential expression may be attributed to hitherto unknown regulatory mechanism of AcrAB-TolC 362 
pump. This phenomenon of variation in expression of genetically identical pump in isolates which 363 
are nearly similar, enhances our perspective on the versatility of resistance mechanisms in gram-364 
negative bacteria.  365 
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Figure Legend 519 
Fig. 1. Schematic representation of Tn4401b bearing blaKPC-2.  520 
Genes and their corresponding transcription orientations are indicated by horizontal arrows. 521 
Tn4401b is delimited by two inverted repeat sequences, IRR and IRL (grey triangles). Small open 522 
triangles represent the inverted repeats of ISKpn6 and ISKpn7.  523 
 524 
Fig. 2. Diagrammatic representation of class 1 integron found in KPC-2 bearing isolates.   525 
arr-2 (ADP-ribosyl transferase), S.ma.I2 (group IIc intron), qacEΔ1 (quaternary ammonium 526 
compound resistance protein), sul1 (sulphonamide resistant dihydropteroate synthase), orf5 (an open 527 
reading frame of unknown function). 528 
 529 
Fig. 3. BRIG analysis of KPC-2-producing K. pneumoniae.  530 
Comparative genome map of KPC-2-producing K. pneumoniae using Klebsiella pneumoniae subsp. 531 
pneumoniae HS11286 as a reference. From the inside out, circle 1 represents the mean centered G+C 532 
content; circle 2 shows GC skew calculated as (G − C) / (G + C); circle 3 to 6 represent the genome 533 
sequence similarity of EN5269 (Kp3), EN5226 (Kp1), EN5271 (Kp4), and EN5261 (Kp2) based on 534 
color gradient against the reference genome. The color gradients indicate the degree matching in the 535 
BLAST result for a shared region, as given to the top right of the ring.  536 
 537 
Fig. 4. Molecular typing and relatedness of KPC-2-producing K. pneumoniae isolates. (A)  538 
Phylogenetic tree analysis among the blaKPC-2 containing isolates under study using iTOL. Branch 539 
length has been depicted showing evolutionary differences between the isolates. Kp1 & Kp3 are 540 
closely related so as Kp2 & Kp4. (B) PFGE of XbaI-digested genomic DNA of KPC-2-producing K. 541 
pneumoniae, isolated from blood of 4 septicemic neonates. Lane 1: Kp2; lane 2: Kp1; lane 3: Kp3; 542 
lane 4: Kp4, and lanes M: Salmonella serotype Braenderup H9812 as reference standard. 543 
